[Current status of the use of immunosuppressive agents based on hyperimmune gamma globulins].
D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion / Q000175:diagnosis; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007231:Infant, Newborn; D008722:Methods; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000009:adverse effects / Q000627:therapeutic use*
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins
Estado actual en el uso de los inmunosupresores a base de gamas globulinas hiperinmunes.